Latest
Kanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer TherapiesKanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer Therapies|Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026|SYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership ConversationsSYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership Conversations|AI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product DesignAI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product Design|Tessera Labs Raises $60M in Series A to Automate Enterprise System TransformationsTessera Labs Raises $60M in Series A to Automate Enterprise System Transformations|InstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account ActivationInstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account Activation|Scout Space Raises Up to $18M in Series A to Expand Space Domain Awareness InfrastructureScout Space Raises Up to $18M in Series A to Expand Space Domain Awareness Infrastructure|4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform|Vastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance PlatformVastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance Platform|Altara Raises $7M in Seed Funding to Build AI Platform for Industrial Data IntelligenceAltara Raises $7M in Seed Funding to Build AI Platform for Industrial Data Intelligence|Kanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer TherapiesKanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer Therapies|Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026|SYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership ConversationsSYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership Conversations|AI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product DesignAI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product Design|Tessera Labs Raises $60M in Series A to Automate Enterprise System TransformationsTessera Labs Raises $60M in Series A to Automate Enterprise System Transformations|InstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account ActivationInstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account Activation|Scout Space Raises Up to $18M in Series A to Expand Space Domain Awareness InfrastructureScout Space Raises Up to $18M in Series A to Expand Space Domain Awareness Infrastructure|4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform|Vastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance PlatformVastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance Platform|Altara Raises $7M in Seed Funding to Build AI Platform for Industrial Data IntelligenceAltara Raises $7M in Seed Funding to Build AI Platform for Industrial Data Intelligence
Back to articles

VulcanForms Secures $220M for Digital Metal Manufacturing Platform

In Devens, Massachusetts, VulcanForms did what serious manufacturing companies do when the moment demands it. They raised $220 million in an oversubscribed Series D and did not bother turning it into...

In Devens, Massachusetts, VulcanForms did what serious manufacturing companies do when the moment demands it. They raised $220 million in an oversubscribed Series D and did not bother turning it into a victory lap. This was capital with intent. Led by Eclipse and 1789 Capital, with Washington Harbour, Fontinalis Partners, IEQ Capital, and other strategic partners in the room, the round pushed total funding to roughly $725 million and quietly reinforced a larger message. The United States is done pretending critical metal production can live offshore without consequence.

VulcanForms was never built as a software deck chasing buzz. Founded in 2015 by Martin C. Feldmann and A. John Hart out of MIT, the company was designed to solve three problems metal additive manufacturing kept dodging: throughput, cost, and material performance. The answer was not prettier printers. It was integration. Proprietary laser powder bed fusion systems, precision CNC machining, automation, and AI-driven software stitched into a single digital thread, running 24/7, under one roof, on American soil.

That roof matters. VulcanOne in Devens spans 160,000 square feet and runs more than two megawatts of laser capacity through VulcanForms’ GEN 3 systems. Newburyport adds over 60 advanced CNC machines and decades of machining discipline through the Arwood acquisition. Add AS9100 certification, micron-level precision, fully dense titanium, nickel, steel, aluminum, copper, and cobalt-chrome parts, and you stop calling this additive manufacturing. You start calling it infrastructure.

The timing is not subtle. VulcanForms is already producing parts across aerospace and defense programs, medical devices, semiconductor and compute infrastructure, consumer products, and industrial equipment. The Series D capital is earmarked to expand capacity, advance materials, and build a third Devens facility that will bring roughly 150 more people into the operation. This is scale with fingerprints, not slogans.

Leadership reflects that shift. Kevin Kassekert, Chief Executive Officer, came in from Tesla and Redwood Materials to turn production into muscle. Jay Martin, President, brings decades of commercial execution from Globus Medical, Intuitive Surgical, and Boston Scientific. Eclipse partner Greg Reichow remains close, because factories do not forgive theory. They only reward repetition.

VulcanForms is not selling machines. They are selling certainty. One supplier, one digital system, one domestic chain of custody from powder to finished part. In a world relearning the cost of fragility, VulcanForms is betting that control beats convenience, and the market seems ready to keep listening.